ArticleAesthetic plastic surgery2025
Helium-Based Plasma Radio Frequency Technology for Subdermal Coagulation in the Forehead: A Preliminary, Single-Center Retrospective Study.
Article in Aesthetic plastic surgery, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed, 1 synthesis or guideline pooled it.
- A Systematic Review of Helium Plasma Radiofrequency (Renuvion).Annals of plastic surgery · 2025Pooled it
- Forehead Eyebrow Lift Techniques: Review of the Literature and Critical Appraisal of Long-term Efficacy.Plastic and reconstructive surgery. Global open · 2026Article
- Helium Plasma Radiofrequency for Aesthetic Subdermal Treatment: A Systematic Review and Meta-Analysis.Aesthetic surgery journal. Open forum · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundHelium plasma radio frequency (RF) has emerged as a minimally invasive option for treating facial laxity. This study aims to evaluate its efficacy and safety for addressing forehead and brow laxity and ptosis.
methodsIn this retrospective, single-center study, medical records for 30 consecutive patients treated with helium plasma RF in the forehead and brow from March 2018 to September 2022 were reviewed. Inclusion criteria were age ≥18 years and having undergone treated in the forehead with helium plasma RF. Patients with prior or concurrent brow/forehead interventions were excluded. Primary endpoints were photographic assessments by blinded review and patient satisfaction measured via questionnaire.
resultsOf the 30 patients, seven patients consented to photographic review, and all 30 participated in the patient satisfaction questionnaire. Blinded reviewers correctly identified posttreatment images in 71.4% (5/7) of cases. Patient satisfaction was high, with 100% (30/30) reporting visible improvements and willingness to recommend the procedure. Notable improvements included reduced forehead lines (56.7%), elevated eyebrows (46.7%), and a more youthful appearance (46.7%). Adverse effects were minor and expected, with bruising recorded in 20% (6/30) of patients and edema/swelling in 16.7% (5/30) of patients, all resolving within 10 days, without intervention.
conclusionHelium plasma RF demonstrates significant potential as a minimally invasive treatment for brow and forehead laxity, with high patient satisfaction and a favorable safety profile. These preliminary findings warrant further prospective studies with larger sample sizes to confirm efficacy and long-term benefits. Helium plasma RF may provide a valuable alternative to traditional aesthetic procedures for the forehead and brow. LEVEL OF EVIDENCE IV: This journal requires that authors assign a level of evidence to each article. For a full description of these Evidence-Based Medicine ratings, please refer to the Table of Contents or the online Instructions to Authors www.springer.com/00266 .
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.